Carney 复合征中生长激素过多的谱系及基因型-表型相关性
该研究纳入 1995 至 2021 年在本中心至少完成一次生长激素分泌生化评估的 Carney 复合征(CNC)患者 140 例,50 例(35.7%)存在生长激素过多(GHE),28 例(20%)为有症状肢端肥大症,诊断中位年龄分别为 25.3 岁和 26.1 岁。99.3% 的患者携带 PRKAR1A 基因缺陷;导致受累等位基因不表达的变异(HR 3.06,95%CI 1.2-7.8)和热点变异 c.491_492delTG(HR 2.10,95%CI 1.1-4.1)与 GHE 风险升高相关。垂体影像异常者 GHE 风险更高(HR 2.94,95%CI 1.5-5.8)。
要点
- CNC 患者中 GHE 占 35.7%,有症状肢端肥大症占 20%,诊断中位年龄分别为 25.3 岁和 26.1 岁。
- 导致受累等位基因不表达的 PRKAR1A 变异者 GHE 风险 HR 3.06(95%CI 1.2-7.8)。
- 垂体影像异常者 GHE 风险 HR 2.94(95%CI 1.5-5.8),尤其见于单个或多个腺瘤样病变。
核心结论
- 生长激素分泌失调是 Carney 复合征的常见表现,了解其临床谱及其与患者遗传和影像学特征的相关性有助于更及时诊断和更好管理。
研究设计与样本
- 纳入 1995 至 2021 年在本中心至少完成一次生长激素分泌生化评估的 Carney 复合征患者 140 例。
- GHE 诊断依据 IGF-1 水平、口服葡萄糖耐量试验中 GH 抑制、促甲状腺素给药后 GH 刺激及夜间 GH 分泌。
主要发现
- 50 例(35.7%)存在 GHE,28 例(20%)为有症状肢端肥大症,诊断中位年龄分别为 25.3 岁和 26.1 岁。
- 99.3% 的患者携带 PRKAR1A 基因缺陷。
- 导致受累等位基因不表达的变异者 GHE 风险 HR 3.06(95%CI 1.2-7.8)。
- 携带热点变异 c.491_492delTG 者 GHE 风险 HR 2.10(95%CI 1.1-4.1)。
- 垂体影像异常者 GHE 风险 HR 2.94(95%CI 1.5-5.8),尤其当识别出单个或多个腺瘤样病变时。
关键数值与推荐
- GHE 诊断依据 IGF-1 水平、口服葡萄糖耐量试验中 GH 抑制、促甲状腺素给药后 GH 刺激及夜间 GH 分泌。
- 近半数 Carney 复合征患者垂体影像学检查有异常发现。
- 有症状肢端肥大症的管理涉及手术和药物治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Carney complex (CNC) is a familial neoplasia syndrome associated with GH excess (GHE). OBJECTIVE: To describe the frequency of GHE in a large cohort of patients with CNC and to identify genotype-phenotype correlations. METHODS: Patients with CNC with at least 1 biochemical evaluation of GH secretion at our center from 1995 to 2021 (n = 140) were included in the study. Diagnosis of GHE was based on levels of IGF-1, GH suppression during oral glucose tolerance test, GH stimulation after thyrotropin administration and overnight GH secretion. RESULTS: Fifty patients (35.7%) had GHE, and 28 subjects (20%) had symptomatic acromegaly, with median age at diagnosis of 25.3 and 26.1 years, respectively. Most of the patients (99.3%) had a PRKAR1A gene defect. There was a higher risk of GHE in patients harboring a variant that led to no expression of the affected allele [hazard risk (HR): 3.06, 95% confidence interval (CI): 1.2-7.8] and for patients harboring the hotspot variant c.491_492delTG (HR: 2.10, 95% CI: 1.1-4.1). Almost half of patients with CNC had an abnormal finding on pituitary imaging. CNC patients with abnormal pituitary imaging had a higher risk of GHE (HR: 2.94, 95% CI: 1.5-5.8), especially when single or multiple adenoma-like lesions were identified. Management of patients with symptomatic acromegaly involved surgical and medical approaches. CONCLUSION: Dysregulation of GH secretion is a common finding in CNC. Knowing the clinical spectrum of this disorder and its association with genetic and imaging characteristics of the patient make more likely its prompt diagnosis and better management.
引用
- Tatsi C, Pitsava G, Faucz FR, et al. The Spectrum of GH Excess in Carney Complex and Genotype-phenotype Correlations. J Clin Endocrinol Metab. 2025. PMID: 38626285. doi:10.1210/clinem/dgae253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。